ASHIMA BAHL: Open Payments
NPI 1477672228 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,229 in 166 payments from 28 companies in 2025. Trend: 2023 $36,575 · 2024 $9,323 · 2025 $14,229
Honoraria: $5,850Food & beverage: $3,580Travel & lodging: $2,496Speaker / faculty: $2,240Education: $63
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 28 | $7,487 |
| Impel Pharmaceuticals LLC | 9 | $3,898 |
| Lundbeck LLC | 17 | $502 |
| PFIZER INC. | 27 | $372 |
| ABBVIE INC. | 18 | $337 |
| Teva Pharmaceuticals USA, Inc. | 12 | $257 |
| JAZZ PHARMACEUTICALS INC. | 8 | $212 |
| ACADIA Pharmaceuticals Inc | 6 | $168 |
| Janssen Scientific Affairs, LLC | 1 | $149 |
| UCB, Inc. | 9 | $141 |
Products named: Symbravo, Trudhesa, VYEPTI, NURTEC ODT, AUSTEDO XR, NUPLAZID, TREMFYA, BOTOX.
Industry payments across FL — which companies pay providers there.
